Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cosopt Versus Xalacom in Glaucoma and Ocular Hypertension
NCT00273481Phase 4Completed
- Sponsor
- PRN Pharmaceutical Research Network
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial of dorzolamide and timolol in open-angle glaucoma (OAG) and ocular hypertension (2 arms), sponsored by PRN Pharmaceutical Research Network. Primary endpoint: Intraocular Pressure at 12 weeks. Started Sep 2005; status: completed.
02
Drugs
dorzolamidetimolol
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00273481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00273481.